Bioventus (BVS) Non Operating Interest Expenses (2020 - 2021)
Bioventus' (BVS) quarterly Non Operating Interest Expenses came in at $419000.0 in Q2 2021, up 404.82% on a YoY basis from $83000.0 in Q2 2020, and up 404.82% quarter-over-quarter from $83000.0 in Q1 2020.
Powered by 
Analysis
Bioventus (BVS) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends
Bioventus (BVS) has reported Non Operating Interest Expenses for 2 consecutive years, with $419000.0 the latest figure, recorded in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | - |